Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Renal Failure

  Free Subscription

Articles published in
Am J Nephrol
    October 2017
  1. WEIR MR, Pergola PE, Agarwal RL, Fink JC, et al
    A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease.
    Am J Nephrol. 2017;46:364-370.
    >> Share

  2. MADUELL F, Varas J, Ramos R, Martin-Malo A, et al
    Hemodiafiltration Reduces All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients: A Propensity-Matched Cohort Study.
    Am J Nephrol. 2017;46:288-297.
    >> Share

    September 2017
  3. MUREA M, Brown WM, Divers J, Moossavi S, et al
    Vascular Access Placement Order and Outcomes in Hemodialysis Patients: A Longitudinal Study.
    Am J Nephrol. 2017;46:268-275.
    >> Share

  4. LEONBERG-YOO AK, Rudnick MR
    Tobacco Use: A Chronic Kidney Disease Accelerant.
    Am J Nephrol. 2017;46:257-259.
    >> Share

  5. ROEHM B, Simoni J, Pruszynski J, Wesson DE, et al
    Cigarette Smoking Attenuates Kidney Protection by Angiotensin-Converting Enzyme Inhibition in Nondiabetic Chronic Kidney Disease.
    Am J Nephrol. 2017;46:260-267.
    >> Share

  6. LIN MC, Streja E, Soohoo M, Hanna M, et al
    Warfarin Use and Increased Mortality in End-Stage Renal Disease.
    Am J Nephrol. 2017;46:249-256.
    >> Share

  7. BAIARDI S, Mondini S, Baldi Antognini A, Santoro A, et al
    Survival of Dialysis Patients with Restless Legs Syndrome: A 15-Year Follow-Up Study.
    Am J Nephrol. 2017;46:224-230.
    >> Share

  8. COLLINS AJ, Pitt B, Reaven N, Funk S, et al
    Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes.
    Am J Nephrol. 2017;46:213-221.
    >> Share

  9. YU J, Ravel VA, You AS, Streja E, et al
    Association between Testosterone and Mortality Risk among U.S. Males Receiving Dialysis.
    Am J Nephrol. 2017;46:195-203.
    >> Share

    August 2017
  10. NARA M, Komatsuda A, Numakura K, Saito M, et al
    Quantification of Interstitial Fibrosis in Renal Allografts and Clinical Correlates of Long-Term Graft Function.
    Am J Nephrol. 2017;46:187-194.
    >> Share

  11. HARDING K, Mersha TB, Webb FA, Vassalotti JA, et al
    Current State and Future Trends to Optimize the Care of African Americans with End-Stage Renal Disease.
    Am J Nephrol. 2017;46:156-164.
    >> Share

  12. HARDING K, Mersha TB, Vassalotti JA, Webb FA, et al
    Current State and Future Trends to Optimize the Care of Chronic Kidney Disease in African Americans.
    Am J Nephrol. 2017;46:176-186.
    >> Share

    July 2017
  13. RIBEIRO SC, Figueiredo AE, Barretti P, Pecoits-Filho R, et al
    Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients.
    Am J Nephrol. 2017;46:150-155.
    >> Share

  14. HAMDI T, Palmer BF
    Review of Extracorporeal Membrane Oxygenation and Dialysis-Based Liver Support Devices for the Use of Nephrologists.
    Am J Nephrol. 2017;46:139-149.
    >> Share

  15. BRAR A, Mallappallil M, Stefanov DG, Kau D, et al
    Dialysis in the Elderly and Impact of Institutionalization in the United States Renal Data System.
    Am J Nephrol. 2017;46:114-119.
    >> Share

  16. KIM T, Streja E, Soohoo M, Rhee CM, et al
    Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients.
    Am J Nephrol. 2017;46:120-130.
    >> Share

  17. ABE M, Hamano T, Wada A, Nakai S, et al
    High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry.
    Am J Nephrol. 2017;46:82-92.
    >> Share

  18. AFSHINNIA F, Zeng L, Byun J, Gadegbeku CA, et al
    Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease.
    Am J Nephrol. 2017;46:73-81.
    >> Share

    June 2017
  19. LIU W, Wang L, Wei Y, Li X, et al
    Interaction of Soluble CXC Ligand 16 and Cardiac Injury Markers in Hemodialysis Patients.
    Am J Nephrol. 2017;46:64-70.
    >> Share

  20. FERNANDES A, Ribera-Sanchez R, Rodriguez-Carmona A, Lopez-Iglesias A, et al
    Peritoneal Water Transport Characteristics of Diabetic Patients Undergoing Peritoneal Dialysis: A Longitudinal Study.
    Am J Nephrol. 2017;46:47-54.
    >> Share

  21. AVILA M, Mora C, Prado MDC, Zavala M, et al
    Osteoprotegerin Is the Strongest Predictor for Progression of Arterial Calcification in Peritoneal Dialysis Patients.
    Am J Nephrol. 2017;46:39-46.
    >> Share

  22. LENHARD MJ, Maser RE
    Vascular Calcification and Osteoprotegrin in Chronic Kidney Disease.
    Am J Nephrol. 2017;46:37-38.
    >> Share

  23. HASEGAWA T, Zhao J, Fuller DS, Bieber B, et al
    Erythropoietin Hyporesponsiveness in Dialysis Patients: Possible Role of Statins.
    Am J Nephrol. 2017;46:11-17.
    >> Share

  24. UDO A, Goodlad C, Davenport A
    Impact of Diabetes on Extracellular Volume Status in Patients Initiating Peritoneal Dialysis.
    Am J Nephrol. 2017;46:18-25.
    >> Share

    May 2017
  25. HUSSEIN WF, Arramreddy R, Sun SJ, Reiterman M, et al
    Higher Ultrafiltration Rate Is Associated with Longer Dialysis Recovery Time in Patients Undergoing Conventional Hemodialysis.
    Am J Nephrol. 2017;46:3-10.
    >> Share

  26. PLANTINGA LC, Jaar BG
    On the Right Track: Implementing Interventions to Reduce Readmissions in Dialysis Patients.
    Am J Nephrol. 2017;45:549-551.
    >> Share

  27. WANG C, Fu X, Yang Y, Deng J, et al
    A Comparison between Intermittent Peritoneal Dialysis and Automatic Peritoneal Dialysis on Urgent Peritoneal Dialysis.
    Am J Nephrol. 2017;45:540-548.
    >> Share

  28. WINGARD RL, McDougall K, Axley B, Howard A, et al
    Right TraC Post-Hospitalization Care Transitions Program to Reduce Readmissions for Hemodialysis Patients.
    Am J Nephrol. 2017;45:532-539.
    >> Share

  29. KIM T, Rhee CM, Streja E, Soohoo M, et al
    Racial and Ethnic Differences in Mortality Associated with Serum Potassium in a Large Hemodialysis Cohort.
    Am J Nephrol. 2017;45:509-521.
    >> Share

  30. LIU YT, Hung TY, Lee YK, Huang MY, et al
    Association between Chronic Kidney Disease and Risk of Cataract: A Nationwide Retrospective Cohort Study.
    Am J Nephrol. 2017;45:524-531.
    >> Share

  31. MACK HG, Savige J
    Chronic Kidney Disease and Cataract: Seeing the Light.
    Am J Nephrol. 2017;45:522-523.
    >> Share

  32. RAIMANN JG, Barth C, Usvyat LA, Preciado P, et al
    Dialysis Access as an Area of Improvement in Elderly Incident Hemodialysis Patients: Results from a Cohort Study from the International Monitoring Dialysis Outcomes Initiative.
    Am J Nephrol. 2017;45:486-496.
    >> Share

  33. NEE R, Fisher E, Yuan CM, Agodoa LY, et al
    Pre-End-Stage Renal Disease Care and Early Survival among Incident Dialysis Patients in the US Military Health System.
    Am J Nephrol. 2017;45:464-472.
    >> Share

  34. YEE J, Campbell RC
    The Interdisciplinary Chronic Kidney Disease Clinic: End of the Beginning, Not Beginning of the End.
    Am J Nephrol. 2017;45:461-463.
    >> Share

  35. ALSHAHAWEY M, Shahin SM, Elsaid TW, Sabri NA, et al
    Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study.
    Am J Nephrol. 2017;45:452-459.
    >> Share

    April 2017
  36. BHANDARI SK, Liu IA, Kujubu DA, Huynh T, et al
    Use of Phosphorus Binders among Non-Dialysis Chronic Kidney Disease Patients and Mortality Outcomes.
    Am J Nephrol. 2017;45:431-441.
    >> Share

  37. FLYTHE JE, Hilbert J, Kshirsagar AV, Gilet CA, et al
    Psychosocial Factors and 30-Day Hospital Readmission among Individuals Receiving Maintenance Dialysis: A Prospective Study.
    Am J Nephrol. 2017;45:400-408.
    >> Share

    March 2017
  38. MARTIN ER, Smith MT, Maroni BJ, Zuraw QC, et al
    Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease.
    Am J Nephrol. 2017;45:380-388.
    >> Share

  39. HAMMES M
    When Is the Right Time for Arteriovenous Fistula Placement in Patients with End-Stage Renal Disease?
    Am J Nephrol. 2017;45:353-355.
    >> Share

  40. MIYAMOTO M, Kurita N, Suemitsu K, Murakami M, et al
    Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients.
    Am J Nephrol. 2017;45:356-364.
    >> Share

  41. YI C, Guo Q, Lin J, Li J, et al
    Patient-Doctor Contact Interval and Clinical Outcomes in Continuous Ambulatory Peritoneal Dialysis Patients.
    Am J Nephrol. 2017;45:346-352.
    >> Share

  42. ILORI TO, Wang X, Huang M, Gutierrez OM, et al
    Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease.
    Am J Nephrol. 2017;45:338-345.
    >> Share

    February 2017
  43. BARAGETTI I, El Essawy B, Fiorina P
    Targeting Immunity in End-Stage Renal Disease.
    Am J Nephrol. 2017;45:310-319.
    >> Share

  44. FAN Q, Yan Y, Gu L, He L, et al
    Prognostic Value of the Delivery Dialysis Dose on Twice-Weekly Hemodialysis Patients.
    Am J Nephrol. 2017;45:273-282.
    >> Share

  45. LANGSFORD D, Tang M, Cheikh Hassan HI, Djurdjev O, et al
    The Association between Biomarker Profiles, Etiology of Chronic Kidney Disease, and Mortality.
    Am J Nephrol. 2017;45:226-234.
    >> Share

    January 2017
  46. WONG LL, Kalantar-Zadeh K, Page V, Hayashida G, et al
    Insights from Screening a Racially and Ethnically Diverse Population for Chronic Kidney Disease.
    Am J Nephrol. 2017;45:200-208.
    >> Share

  47. LOCATELLI F, Fishbane S, Block GA, Macdougall IC, et al
    Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients.
    Am J Nephrol. 2017;45:187-199.
    >> Share

  48. BRAR A, Markell M, Stefanov DG, Timpo E, et al
    Mortality after Renal Allograft Failure and Return to Dialysis.
    Am J Nephrol. 2017;45:180-186.
    >> Share

  49. WOLFGRAM DF, Garcia K, Evans G, Zamanian S, et al
    Association of Albuminuria and Estimated Glomerular Filtration Rate with Functional Performance Measures in Older Adults with Chronic Kidney Disease.
    Am J Nephrol. 2017;45:172-179.
    >> Share

  50. ABAD S, Vega A, Hernandez E, Merida E, et al
    Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4.
    Am J Nephrol. 2017;45:267-272.
    >> Share

  51. VADUGANATHAN M, Bhatt DL
    Cardiac Troponins in Chronic Kidney Disease: A Marker of Global Cardiovascular Risk.
    Am J Nephrol. 2017;45:301-303.
    >> Share

  52. SHARMA K
    Myeloperoxidase Activity and Oxidized Amino Acids as Biomarkers in Chronic Kidney Disease and Coronary Artery Disease.
    Am J Nephrol. 2017;46:71-72.
    >> Share

    December 2016
  53. XUE C, Yang B, Zhou C, Dai B, et al
    Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease.
    Am J Nephrol. 2016;45:149-159.
    >> Share

  54. FILLER G, McIntyre C
    Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?
    Am J Nephrol. 2016;45:146-148.
    >> Share

  55. AKIZAWA T, Tsubakihara Y, Nangaku M, Endo Y, et al
    Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects.
    Am J Nephrol. 2016;45:127-135.
    >> Share

  56. REQUE J, Garcia-Prieto A, Linares T, Vega A, et al
    Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients.
    Am J Nephrol. 2016;45:107-114.
    >> Share

    November 2016
  57. FERREIRA JP, Girerd N, Pannier B, Rossignol P, et al
    High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60.
    Am J Nephrol. 2016;45:72-81.
    >> Share

  58. ZOCCALI C, Mallamaci F
    Arterial Stiffness as a Cardiovascular Risk Factor in Stage 5D Chronic Kidney Disease Patients: An Age Affair.
    Am J Nephrol. 2016;45:69-71.
    >> Share

  59. DE SOUZA VC, Rabilloud M, Cochat P, Wagner MB, et al
    Trajectories and Predictors of Allograft Dysfunction after Renal Transplantation in Children.
    Am J Nephrol. 2016;45:63-68.
    >> Share

  60. THADHANI R, Zella JB, Knutson DC, Blaser WJ, et al
    2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial.
    Am J Nephrol. 2016;45:40-48.
    >> Share

  61. CHOI Y, Shin J, Park JT, Cho KH, et al
    Disparities in Kidney Transplantation Access among Korean Patients Initiating Dialysis: A Population-Based Cohort Study Using National Health Insurance Data (2003-2013).
    Am J Nephrol. 2016;45:32-39.
    >> Share

  62. MCCABE KM, Booth SL, Fu X, Ward E, et al
    Vitamin K Metabolism in a Rat Model of Chronic Kidney Disease.
    Am J Nephrol. 2016;45:4-13.
    >> Share

  63. GALE RC, Kehoe D, Lit YZ, Asch SM, et al
    Effect of a Dialysis Access Coordinator on Preemptive Access Placement among Veterans: A Quality Improvement Initiative.
    Am J Nephrol. 2016;45:14-21.
    >> Share

  64. FUSARO M, Plebani M, Iervasi G, Gallieni M, et al
    Vitamin K Deficiency in Chronic Kidney Disease: Evidence Is Building Up.
    Am J Nephrol. 2016;45:1-3.
    >> Share

  65. SHARMA A, Yabes J, Al Mawed S, Wu C, et al
    Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients.
    Am J Nephrol. 2016;44:462-472.
    >> Share

  66. FOSTER R, Walker S, Brar R, Hiebert B, et al
    Cognitive Impairment in Advanced Chronic Kidney Disease: The Canadian Frailty Observation and Interventions Trial.
    Am J Nephrol. 2016;44:473-480.
    >> Share

    October 2016
  67. NOVICK T, Liu Y, Alvanzo A, Zonderman AB, et al
    Lifetime Cocaine and Opiate Use and Chronic Kidney Disease.
    Am J Nephrol. 2016;44:447-453.
    >> Share

  68. LANOT A, Lobbedez T, Bechade C, Verger C, et al
    Efficacy of Prophylactic Antibiotics at Peritoneal Catheter Insertion on Early Peritonitis: Data from the Catheter Section of the French Language Peritoneal Dialysis Registry.
    Am J Nephrol. 2016;44:419-425.
    >> Share

  69. CHEN TY, Lin TT, Hsieh MY, Lin L, et al
    Circulating Progenitor Cells Affect Thrombosis of Dialysis Arteriovenous Fistulas.
    Am J Nephrol. 2016;44:428-438.
    >> Share

  70. BUSHINSKY DA, Rossignol P, Spiegel DM, Benton WW, et al
    Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis.
    Am J Nephrol. 2016;44:404-410.
    >> Share

  71. MACLAUGHLIN HL, Macdougall IC, Hall WL, Dew T, et al
    Does Intragastric Balloon Treatment for Obesity in Chronic Kidney Disease Heighten Acute Kidney Injury Risk?
    Am J Nephrol. 2016;44:411-418.
    >> Share

  72. SAKURA M, Inaba M, Yoda K, Ichii M, et al
    High Coronary Heart Disease Risk in Hemodialysis Patients with Central Sleep Apnea: A Pilot Study.
    Am J Nephrol. 2016;44:388-395.
    >> Share

  73. CHADE AR, Hall JE
    Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity.
    Am J Nephrol. 2016;44:354-367.
    >> Share

  74. SAKHUJA A, Wright RS, Schold JD, McCarthy JT, et al
    National Impact of Maintenance Dialysis or Renal Transplantation on Outcomes Following ST Elevation Myocardial Infarction.
    Am J Nephrol. 2016;44:329-338.
    >> Share

  75. BOLAD IA
    ST-Segment Elevation Myocardial Elevation in Dialysis and Renal Transplant Patients. How Does It Compare to That in the General Population?
    Am J Nephrol. 2016;44:327-328.
    >> Share

    September 2016
  76. SPRAGUE SM, Crawford PW, Melnick JZ, Strugnell SA, et al
    Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.
    Am J Nephrol. 2016;44:316-325.
    >> Share

  77. SMITH ZG, McNicoll L, Clark TL, Cohen AJ, et al
    Medical Neighborhood Model for the Care of Chronic Kidney Disease Patients.
    Am J Nephrol. 2016;44:308-315.
    >> Share

  78. TRINH E, Chan CT
    Intensive Home Hemodialysis Results in Regression of Left Ventricular Hypertrophy and Better Clinical Outcomes.
    Am J Nephrol. 2016;44:300-307.
    >> Share

  79. WALLQUIST C, Mansouri L, Norrback M, Hylander B, et al
    Early Changes in Monocyte Adhesion Molecule Expression and Tumor Necrosis Factor-alpha Levels in Chronic Kidney Disease - A 5-Year Prospective Study.
    Am J Nephrol. 2016;44:268-275.
    >> Share

  80. GENOVESI S
    Oral Anticoagulation in End-Stage Renal Disease: Is It Time to Absolve Warfarin?
    Am J Nephrol. 2016;44:255-257.
    >> Share

  81. BRANCACCIO D, Neri L, Bellocchio F, Barbieri C, et al
    Patients' Characteristics Affect the Survival Benefit of Warfarin Treatment for Hemodialysis Patients with Atrial Fibrillation. A Historical Cohort Study.
    Am J Nephrol. 2016;44:258-267.
    >> Share

  82. JIANG Y, Shen Z, Zhang J, Xing C, et al
    Parathyroidectomy Increases Heart Rate Variability and Leptin Levels in Patients with Stage 5 Chronic Kidney Disease.
    Am J Nephrol. 2016;44:245-254.
    >> Share

  83. YUSUF AA, Hu Y, Singh B, Menoyo JA, et al
    Serum Potassium Levels and Mortality in Hemodialysis Patients: A Retrospective Cohort Study.
    Am J Nephrol. 2016;44:179-186.
    >> Share

    August 2016
  84. SAKAO Y, Sugimoto M, Ichikawa H, Sahara S, et al
    Severity of Gastric Mucosal Atrophy Is the Major Determinant of Plasma Ghrelin Level in Hemodialysis Patients.
    Am J Nephrol. 2016;44:224-233.
    >> Share

  85. AL DHAYBI O, Bakris G
    New Onset Hypertension Linked to Generic Cyclosporine Substitution in Post-Renal Transplant Patient.
    Am J Nephrol. 2016;44:219-223.
    >> Share

  86. DIAS C, Moore KT, Murphy J, Ariyawansa J, et al
    Rivaroxaban in Chronic Hemodialysis Patients: Clarification of an Editorial Error.
    Am J Nephrol. 2016;44:169.
    >> Share

  87. ROCCO MV, Chapman A, Chertow GM, Cohen D, et al
    Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions.
    Am J Nephrol. 2016;44:130-140.
    >> Share

  88. ALICIC RZ, Short RA, Corbett CL, Neumiller JJ, et al
    Medication Intervention for Chronic Kidney Disease Patients Transitioning from Hospital to Home: Study Design and Baseline Characteristics.
    Am J Nephrol. 2016;44:122-129.
    >> Share

    July 2016
  89. SPRAGUE SM, Covic AC, Floege J, Ketteler M, et al
    Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients.
    Am J Nephrol. 2016;44:104-112.
    >> Share

  90. NORRIS KC, Nicholas SB
    Racial Disparities in End-of-Life Issues in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2016;44:81-83.
    >> Share

  91. KIM HJ, Lee H, Kim DK, Oh KH, et al
    Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients.
    Am J Nephrol. 2016;44:71-80.
    >> Share

  92. LEMOINE S, Panaye M, Pelletier C, Bon C, et al
    Cystatin C-Creatinine Based Glomerular Filtration Rate Equation in Obese Chronic Kidney Disease Patients: Impact of Deindexation and Gender.
    Am J Nephrol. 2016;44:63-70.
    >> Share

  93. LEEHEY DJ, Collins E, Kramer HJ, Cooper C, et al
    Structured Exercise in Obese Diabetic Patients with Chronic Kidney Disease: A Randomized Controlled Trial.
    Am J Nephrol. 2016;44:54-62.
    >> Share

    June 2016
  94. CHAN D, Cheema BS
    Progressive Resistance Training in End-Stage Renal Disease: Systematic Review.
    Am J Nephrol. 2016;44:32-45.
    >> Share

  95. JOHANSEN KL
    Resistance Exercise in the Hemodialysis Population - Who Should Do the Heavy Lifting?
    Am J Nephrol. 2016;44:29-31.
    >> Share

  96. ENEANYA ND, Wenger JB, Waite K, Crittenden S, et al
    Racial Disparities in End-of-Life Communication and Preferences among Chronic Kidney Disease Patients.
    Am J Nephrol. 2016;44:46-53.
    >> Share

  97. TASEVSKA I, Enhorning S, Christensson A, Persson M, et al
    Increased Levels of Copeptin, a Surrogate Marker of Arginine Vasopressin, Are Associated with an Increased Risk of Chronic Kidney Disease in a General Population.
    Am J Nephrol. 2016;44:22-28.
    >> Share

  98. SHIRAZIAN S, Diep R, Jacobson AM, Grant CD, et al
    Awareness of Chronic Kidney Disease and Depressive Symptoms: National Health and Nutrition Examination Surveys 2005-2010.
    Am J Nephrol. 2016;44:1-10.
    >> Share

    May 2016
  99. VASCO RF, Moyses RM, Zatz R, Elias RM, et al
    Furosemide Increases the Risk of Hyperparathyroidism in Chronic Kidney Disease.
    Am J Nephrol. 2016;43:421-430.
    >> Share

  100. WESSON DE
    Does an Acid-Milieu in Chronic Kidney Disease Contribute to Its Increased Cardiovascular Mortality?
    Am J Nephrol. 2016;43:408-410.
    >> Share

  101. DOBRE M, Roy J, Tao K, Anderson AH, et al
    Serum Bicarbonate and Structural and Functional Cardiac Abnormalities in Chronic Kidney Disease - A Report from the Chronic Renal Insufficiency Cohort Study.
    Am J Nephrol. 2016;43:411-420.
    >> Share

  102. RHEE EP, Clish CB, Wenger J, Roy J, et al
    Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study.
    Am J Nephrol. 2016;43:366-374.
    >> Share

  103. LEE T, Thamer M, Zhang Q, Zhang Y, et al
    Reduced Cardiovascular Mortality Associated with Early Vascular Access Placement in Elderly Patients with Chronic Kidney Disease.
    Am J Nephrol. 2016;43:334-340.
    >> Share

  104. CLARK WF, Sontrop JM, Huang SH, Moist L, et al
    Hydration and Chronic Kidney Disease Progression: A Critical Review of the Evidence.
    Am J Nephrol. 2016;43:281-292.
    >> Share

    April 2016
  105. BROWN JR, Rezaee ME, Hisey WM, Cox KC, et al
    Reduced Mortality Associated with Acute Kidney Injury Requiring Dialysis in the United States.
    Am J Nephrol. 2016;43:261-270.
    >> Share

    January 2016
  106. SRINIVAS T
    Brain Imaging and Cognition after Kidney Transplantation.
    Am J Nephrol. 2016;43:47-9.
    >> Share

    August 2015
  107. RUBIN MF, Weir MR
    Access to Kidney Transplantation: Is There a Potential Conflict of Interest?
    Am J Nephrol. 2015;41:502-503.
    >> Share

    July 2015
  108. HUANG E, Bunnapradist S
    Pre-Transplant Weight Loss and Survival after Kidney Transplantation.
    Am J Nephrol. 2015;41:448-455.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016